Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Apellis Pharmaceuticals granted E.U. orphan drug designation for APL-2 in PNH

May 10, 2017

Tavalisse accepted as proprietary name for fostamatinib disodium in U.S.

April 28, 2017

Akebia and Otsuka expand vadadustat collaboration

April 26, 2017

EMA grants PRIME designation to AMT-060 in hemophilia B

April 26, 2017

Akari presents new data on Coversin

April 25, 2017

Interim results from phase III HAVEN 2 pediatric trial of emicizumab in hemophilia A

April 18, 2017

Rigel submits NDA for fostamatinib for chronic ITP

April 18, 2017

BioCryst Pharmaceuticals announces plans to test oral liquid formulation of BCX-7353

April 13, 2017

Achillion initiates phase II study of ACH-4471 in paroxysmal nocturnal hemoglobinuria

April 7, 2017

ProMetic Life Sciences completes plasminogen BLA filing

April 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...